chr18-46577732-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001384474.1(LOXHD1):​c.1945G>A​(p.Asp649Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000645 in 1,551,514 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0033 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 6 hom. )

Consequence

LOXHD1
NM_001384474.1 missense

Scores

4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 1.73

Publications

5 publications found
Variant links:
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
LOXHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 77
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Fuchs' endothelial dystrophy
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005555272).
BP6
Variant 18-46577732-C-T is Benign according to our data. Variant chr18-46577732-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178401.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0033 (503/152286) while in subpopulation AFR AF = 0.0109 (454/41562). AF 95% confidence interval is 0.0101. There are 3 homozygotes in GnomAd4. There are 259 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOXHD1NM_001384474.1 linkc.1945G>A p.Asp649Asn missense_variant Exon 14 of 41 ENST00000642948.1 NP_001371403.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LOXHD1ENST00000642948.1 linkc.1945G>A p.Asp649Asn missense_variant Exon 14 of 41 NM_001384474.1 ENSP00000496347.1 A0A2R8Y7K4
LOXHD1ENST00000536736.5 linkc.1945G>A p.Asp649Asn missense_variant Exon 14 of 40 5 ENSP00000444586.1 F5GZB4
LOXHD1ENST00000441551.6 linkc.1945G>A p.Asp649Asn missense_variant Exon 14 of 39 5 ENSP00000387621.2 Q8IVV2-1
LOXHD1ENST00000335730.6 linkn.1258G>A non_coding_transcript_exon_variant Exon 7 of 27 2

Frequencies

GnomAD3 genomes
AF:
0.00331
AC:
503
AN:
152168
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000875
AC:
138
AN:
157772
AF XY:
0.000746
show subpopulations
Gnomad AFR exome
AF:
0.0131
Gnomad AMR exome
AF:
0.000768
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000884
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000331
Gnomad OTH exome
AF:
0.000450
GnomAD4 exome
AF:
0.000355
AC:
497
AN:
1399228
Hom.:
6
Cov.:
31
AF XY:
0.000316
AC XY:
218
AN XY:
690084
show subpopulations
African (AFR)
AF:
0.0118
AC:
372
AN:
31596
American (AMR)
AF:
0.00115
AC:
41
AN:
35702
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25178
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35736
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49272
Middle Eastern (MID)
AF:
0.00105
AC:
6
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000158
AC:
17
AN:
1078818
Other (OTH)
AF:
0.00102
AC:
59
AN:
57996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00330
AC:
503
AN:
152286
Hom.:
3
Cov.:
32
AF XY:
0.00348
AC XY:
259
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0109
AC:
454
AN:
41562
American (AMR)
AF:
0.00261
AC:
40
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68022
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00112
Hom.:
2
Bravo
AF:
0.00362
ESP6500AA
AF:
0.0137
AC:
19
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00135
AC:
36
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive nonsyndromic hearing loss 77 Uncertain:1Benign:2
Jan 06, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 11, 2018
Counsyl
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not provided Benign:3
Mar 21, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 20, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asp649Asn in Exon 14 of LOXHD1: This variant is not expected to have clinical si gnificance because it has been identified in 1.6% (11/702) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs141932807). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
23
DANN
Uncertain
0.99
Eigen
Benign
0.11
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.91
D;D;D
MetaRNN
Benign
0.0056
T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
1.7
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.6
N;.;.
REVEL
Benign
0.090
Sift
Benign
0.16
T;.;.
Sift4G
Benign
0.22
T;.;T
Polyphen
0.96
D;.;.
Vest4
0.24
MVP
0.18
ClinPred
0.016
T
GERP RS
5.7
Varity_R
0.11
gMVP
0.23
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141932807; hg19: chr18-44157695; API